Table 3. Correlation between CDCA2 expression and clinical characteristics in TMA(n = 92).
Characteristics | CDCA2-low cases | CDCA2-high cases | P value |
---|---|---|---|
Age at diagnosis(years) | 0.1420 | ||
≤ 60 | 22 | 29 | |
> 60 | 24 | 17 | |
Gender | 0.2413 | ||
Male | 36 | 31 | |
Female | 10 | 15 | |
Differentiation | 0.0220* | ||
Well | 17 | 8 | |
Moderate | 12 | 8 | |
Poor | 17 | 30 | |
Primary tumor size | 0.0025* | ||
T1 | 24 | 10 | |
T2–4 | 22 | 36 | |
Lymph node status | 0.0940 | ||
N0 | 29 | 21 | |
N1–3 | 17 | 25 | |
Tumor stage | 0.0171* | ||
I | 20 | 14 | |
II | 16 | 9 | |
III | 10 | 23 |
* Significant correlation.